128 related articles for article (PubMed ID: 340084)
1. Radiosensitizers in the treatment of squamous cell carcinoma of the head and neck.
Dische S
Clin Otolaryngol Allied Sci; 1977 Nov; 2(4):403-9. PubMed ID: 340084
[No Abstract] [Full Text] [Related]
2. The treatment of locally advanced head and neck cancer with misonidazole, hyperbaric oxygen and irradiation: an interim report.
Sealy R; Cridland S
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1721-3. PubMed ID: 6384161
[TBL] [Abstract][Full Text] [Related]
3. Irradiation with misonidazole and hyperbaric oxygen: final report on a randomized trial in advanced head and neck cancer.
Sealy R; Cridland S; Barry L; Norris R
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1343-6. PubMed ID: 3531113
[TBL] [Abstract][Full Text] [Related]
4. [Radiosensitization of hypoxic tumor cells with special reference to head and neck cancers].
Kogelnik HD
Wien Klin Wochenschr; 1983 Aug; 95(15):515-8. PubMed ID: 6636784
[TBL] [Abstract][Full Text] [Related]
5. Hypoxic Cell Radiosensitization in Head and Neck Squamous Cell Carcinoma: Running Out of Air.
Morse RT; Mell LK
Int J Radiat Oncol Biol Phys; 2024 Jul; 119(3):783-785. PubMed ID: 38851276
[No Abstract] [Full Text] [Related]
6. Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome: in regard to Evans et al. (Int J Radiat Oncol Biol Phys 2007;69:1024-1031).
Bussink J; van der Kogel AJ; Kaanders JH
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1616. PubMed ID: 18374238
[No Abstract] [Full Text] [Related]
7. Hyperfractionated radiotherapy with or without misonidazole: results of a prospective randomized study in stage III-IV squamous cell carcinoma of the head and neck.
Panis X; Nguyen TD; Froissart D; Demange L
Int J Radiat Oncol Biol Phys; 1984 Oct; 10(10):1845-9. PubMed ID: 6386760
[TBL] [Abstract][Full Text] [Related]
8. Treatment of head and neck cancer with hybaroxic radiotherapy.
Wildermuth O
Proc Natl Cancer Conf; 1970; 6():639-44. PubMed ID: 5458128
[No Abstract] [Full Text] [Related]
9. The treatment of locally advanced cancer of the head and neck with intra-arterial cytotoxics, cobalt, and hyperbaric oxygen therapy.
Sealy R; Helman P; Greenstein A; Shepstone B
Cancer; 1974 Sep; 34(3):497-500. PubMed ID: 4855130
[No Abstract] [Full Text] [Related]
10. [Effect of metronidazole on the radiosensitivity of Guerin's carcinoma during its growth].
Rudakov NP; Kindzel'skiĭ LP; Zlochevskaia LL
Med Radiol (Mosk); 1985 Mar; 30(3):76-7. PubMed ID: 3982262
[No Abstract] [Full Text] [Related]
11. Double blind controlled clinical trial of radiation plus razoxane (ICRF 159) versus radiation plus placebo in the treatment of head and neck cancer.
Bakowski MT; Macdonald E; Mould RF; Cawte P; Sloggem J; Barrett A; Dalley V; Newton KA; Westbury G; James SE; Hellmann K
Int J Radiat Oncol Biol Phys; 1978; 4(1-2):115-9. PubMed ID: 344287
[No Abstract] [Full Text] [Related]
12. Radiosensitization of hypoxic tumor cells by simultaneous administration of hyperthermia and nitroimidazoles.
Hofer KG; Hofer MG; Ieracitano J; McLaughlin WH
Radiat Res; 1977 May; 70(2):362-77. PubMed ID: 860011
[No Abstract] [Full Text] [Related]
13. First analysis of tumor regression for the European randomized trial of etanidazole combined with radiotherapy in head and neck carcinomas.
Chassagne D; Charreau I; Sancho-Garnier H; Eschwege F; Malaise EP
Int J Radiat Oncol Biol Phys; 1992; 22(3):581-4. PubMed ID: 1531218
[TBL] [Abstract][Full Text] [Related]
14. A systematic assessment of radiation dose enhancement by 5-Aza-2'-deoxycytidine and histone deacetylase inhibitors in head-and-neck squamous cell carcinoma.
De Schutter H; Kimpe M; Isebaert S; Nuyts S
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):904-12. PubMed ID: 19215824
[TBL] [Abstract][Full Text] [Related]
15. A clinical study to assess chlorpromazine as hypoxic cell sensitizer in head & neck cancer treated with conventional radiation.
Huilgol NG; Chatterjee N; Singh BB
Indian J Cancer; 1998 Sep; 35(3):97-100. PubMed ID: 10226398
[TBL] [Abstract][Full Text] [Related]
16. Hypoxic cell radiosensitizers.
Fowler JF
Strahlentherapie Sonderb; 1978; 75():12-9. PubMed ID: 400196
[No Abstract] [Full Text] [Related]
17. NIMRAD - a phase III trial to investigate the use of nimorazole hypoxia modification with intensity-modulated radiotherapy in head and neck cancer.
Thomson D; Yang H; Baines H; Miles E; Bolton S; West C; Slevin N
Clin Oncol (R Coll Radiol); 2014 Jun; 26(6):344-7. PubMed ID: 24685344
[No Abstract] [Full Text] [Related]
18. Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck.
Leonard CE; Chan DC; Chou TC; Kumar R; Bunn PA
Cancer Res; 1996 Nov; 56(22):5198-204. PubMed ID: 8912857
[TBL] [Abstract][Full Text] [Related]
19. Does hyperbaric oxygen have a future in radiation therapy?
Henk JM
Int J Radiat Oncol Biol Phys; 1981 Aug; 7(8):1125-8. PubMed ID: 7028699
[No Abstract] [Full Text] [Related]
20. Hyperbaric oxygen therapy.
Feldmeier JJ; Court WS; Davolt DA; Stegmann B; Heimbach RD; Sheffield PT
Otolaryngol Head Neck Surg; 1997 Jun; 116(6 Pt 1):703-4. PubMed ID: 9215393
[No Abstract] [Full Text] [Related]
[Next] [New Search]
